PL3532072T3 - Leczenie jaskry - Google Patents

Leczenie jaskry

Info

Publication number
PL3532072T3
PL3532072T3 PL18727467T PL18727467T PL3532072T3 PL 3532072 T3 PL3532072 T3 PL 3532072T3 PL 18727467 T PL18727467 T PL 18727467T PL 18727467 T PL18727467 T PL 18727467T PL 3532072 T3 PL3532072 T3 PL 3532072T3
Authority
PL
Poland
Prior art keywords
glaucoma
treatment
Prior art date
Application number
PL18727467T
Other languages
English (en)
Polish (pl)
Inventor
Lars Bruce
Adam Bruce
Original Assignee
Tx Medic Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tx Medic Ab filed Critical Tx Medic Ab
Priority claimed from PCT/SE2018/050506 external-priority patent/WO2018212708A1/en
Publication of PL3532072T3 publication Critical patent/PL3532072T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
PL18727467T 2017-05-17 2018-05-16 Leczenie jaskry PL3532072T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE1750615 2017-05-17
US201762555848P 2017-09-08 2017-09-08
PCT/SE2018/050506 WO2018212708A1 (en) 2017-05-17 2018-05-16 Treatment of glaucoma
EP18727467.5A EP3532072B1 (en) 2017-05-17 2018-05-16 Treatment of glaucoma

Publications (1)

Publication Number Publication Date
PL3532072T3 true PL3532072T3 (pl) 2020-09-21

Family

ID=62245395

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18727467T PL3532072T3 (pl) 2017-05-17 2018-05-16 Leczenie jaskry

Country Status (12)

Country Link
US (1) US11291684B2 (https=)
EP (1) EP3532072B1 (https=)
JP (1) JP6817466B2 (https=)
KR (1) KR102331421B1 (https=)
CN (1) CN110621320B (https=)
CA (1) CA3063851C (https=)
DK (1) DK3532072T3 (https=)
ES (1) ES2777836T3 (https=)
IL (1) IL270362B (https=)
PL (1) PL3532072T3 (https=)
PT (1) PT3532072T (https=)
RU (1) RU2759998C2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3074987A1 (en) * 2017-09-08 2019-03-14 Tx Medic Ab New use of dextran sulfate
GB202008919D0 (en) * 2020-06-11 2020-07-29 Univ Birmingham Polysaccharide conpositions and therapeutic gels
CN115531417B (zh) * 2022-11-14 2024-04-09 青岛海尔生物科技有限公司 ITGA6阳性iPSC源小梁网类细胞在制备治疗高眼压疾病药物中的应用及筛选方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238482A (en) * 1978-09-29 1980-12-09 Peyman Gholam A Intraocular infusion irrigation solution and method
DE3705669A1 (de) 1987-02-21 1988-09-01 Thomae Gmbh Dr K Verwendung von dextransulfat zur herstellung eines arzneimittels zur behandlung und prophylaxe von gefaessverengungen und gefaessverschluessen
JPH02223525A (ja) * 1988-11-16 1990-09-05 Takeda Chem Ind Ltd 血管新生阻害剤
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
US5227372A (en) 1990-03-07 1993-07-13 Children's Medical Center Corporation Method for retaining ophthalmological agents in ocular tissues
CA2020199C (en) 1990-06-29 2002-08-20 Daniel Bar-Shalom Uses of sulphated sugars
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
CA2331620A1 (en) 1998-05-11 1999-11-18 The Endowment For Research In Human Biology, Inc. Use of neomycin for treating angiogenesis-related diseases
GB9917092D0 (en) 1999-07-22 1999-09-22 Ml Lab Plc Treatment of angiogenesis-dependent conditions
WO2005110438A2 (en) 2004-04-15 2005-11-24 Massachusetts Institute Of Technology Methods and products related to the intracellular delivery of polysaccharides
SE0401182D0 (sv) 2004-05-05 2004-05-05 Q Med Ab Novel use of a viscoelastic composition
US20060154894A1 (en) 2004-09-15 2006-07-13 Massachusetts Institute Of Technology Biologically active surfaces and methods of their use
WO2007002139A2 (en) 2005-06-22 2007-01-04 The Trustees Of The University Of Pennsylvania Neuroprotection of retinal ganglion cells
US20140186339A1 (en) * 2006-10-27 2014-07-03 Lpath, Inc. Compositions and methods for treating ocular diseases and conditions
US20130273096A1 (en) 2011-10-05 2013-10-17 Bruce A. Daniels Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients
EP3142684A4 (en) * 2014-05-12 2018-05-23 Purdue Research Foundation Selectin and icam/vcam peptide ligand conjugates
WO2015190989A1 (en) 2014-06-12 2015-12-17 Tx Medic Ab The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
SE539575C2 (en) * 2015-07-30 2017-10-17 Tx Medic Ab Dextran sulfate for use in treating, inhibiting or preventing cardiac fibrosis
CN107137421A (zh) 2017-05-25 2017-09-08 青岛市中心医院 硫酸葡聚糖在制备抑制角膜血管新生药物中的应用

Also Published As

Publication number Publication date
ES2777836T3 (es) 2020-08-06
EP3532072B1 (en) 2020-01-01
EP3532072A1 (en) 2019-09-04
KR102331421B1 (ko) 2021-11-25
CA3063851C (en) 2023-09-19
IL270362B (en) 2021-04-29
BR112019024087A2 (pt) 2020-06-02
CN110621320A (zh) 2019-12-27
JP2020519742A (ja) 2020-07-02
RU2019136633A (ru) 2021-06-17
RU2759998C2 (ru) 2021-11-22
KR20200005560A (ko) 2020-01-15
US20210315920A1 (en) 2021-10-14
RU2019136633A3 (https=) 2021-06-17
PT3532072T (pt) 2020-03-05
US11291684B2 (en) 2022-04-05
CA3063851A1 (en) 2018-11-22
JP6817466B2 (ja) 2021-01-20
CN110621320B (zh) 2023-03-17
DK3532072T3 (da) 2020-04-06

Similar Documents

Publication Publication Date Title
ZA202006746B (en) Methods of treatment
IL268694A (en) Treatment of schizophrenia
GB201804514D0 (en) Treatment of pyroptosis
IL267229A (en) Methods of treating ocular disorders
IL290069A (en) Methods for treating eye conditions
IL270781A (en) Treatment of depressive disorders
IL251769A0 (en) Methods for treating eye conditions
GB201804515D0 (en) Treatment of necroptosis
GB201607388D0 (en) Treatment of impulsivity-related disorders
IL270362B (en) Glaucoma treatment
SG11202005850VA (en) Methods of treatment of hypertrigl yceridemia
GB201607797D0 (en) Glaucoma therapy
ZA202002910B (en) Treatment of skin disorders
IL273543A (en) A new treatment for SMA
LT3638370T (lt) Migrenos gydymas acetilleucinu
GB201713760D0 (en) Treatment of epilepsy
EP3271017A4 (en) Treatment of skin conditions
IL263837A (en) Treatment of ocular disease
GB201604359D0 (en) Treatment of tissue disorders
GB201805556D0 (en) Treatment of ophthalmological conditions
HK40038038A (en) Methods of treatment of hypertrigl yceridemia
GB201801249D0 (en) Methods of treatment
GB201522828D0 (en) Prevention and treatment of glaucoma
AU2017902737A0 (en) Treatment of ocular conditions
GB201705435D0 (en) Treatment of ocular disease